A Dark Vector Cognition product

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

3K characters. Original on sec.gov · Markdown

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

| --- | --- |

The following table includes information about the company’s common stock repurchases during the three-month period ended December 31, 2017.

PeriodTotal Number of Shares Purchased(1)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Programs(1)Approximate Dollar Value of Shares that may yet be Purchased Under the Program(1)
October 1, 2017 through October 31, 2017328,500$62.41328,500
November 1, 2017 through November 30, 20172,332,814$64.302,332,814
December 1, 2017 through December 31, 20171,834,400$64.821,834,400
Total4,495,714$64.374,495,714$1,119,190,080
(1)On July 25, 2012, the company announced that its Board of Directors authorized the company to repurchase up to $2.0 billion of its common stock on the open market or in private transactions. The Board of Directors increased this authority by $1.5 billion in November 2016. During the fourth quarter of 2017, the company repurchased approximately 4.5 million shares for $289 million in cash pursuant to this authority through Rule 10b5-1 purchase plans. The remaining authorization under this program totaled approximately $1.1 billion at December 31, 2017. The Board of Directors increased this authority by an additional $1.5 billion in February 2018. After giving effect to the February 2018 approval and 2018 share repurchases, $2.3 billion of repurchase authority remained available as of February 20, 2018. This program does not have an expiration date.

Baxter common stock is listed on the New York, Chicago and SIX Swiss stock exchanges. The New York Stock Exchange is the principal market on which the company’s common stock is traded. At January 31, 2018, there were 26,370 holders of record of the company’s common stock.

Performance Graph

The following graph compares the change in Baxter’s cumulative total shareholder return (including reinvested dividends) on Baxter’s common stock with the Standard & Poor’s 500 Composite Index and the Standard & Poor’s 500 Health Care Index over the past five years. Performance through June 30, 2015 has been adjusted for the Baxalta separation which occurred on July 1, 2015.

Previous: Item 4. Mine Safety Disclosures. · Next: Item 6. Selected Financial Data.